alpha-N-Acetyl-D-galactosamine
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- alpha-N-Acetyl-D-galactosamine
- DrugBank Accession Number
- DB03567
- Background
The N-acetyl derivative of galactosamine. [PubChem]
- Type
- Small Molecule
- Groups
- Experimental, Investigational
- Structure
- Weight
- Average: 221.2078
Monoisotopic: 221.089937217 - Chemical Formula
- C8H15NO6
- Synonyms
- GalNAc-α
- N-acetyl-2-deoxy-2-amino-galactose
- N-acetyl-alpha-D-galactosamine
- N-acetyl-α-D-galactosamine
- Tn antigen saccharide
- Tn antigen saccharide component
- Tn saccharide
- Tn saccharide component
- α-GalNAc
- α-GalpNAc
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as n-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moiety in which the oxygen atom is replaced by an n-acyl group.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbohydrates and carbohydrate conjugates
- Direct Parent
- N-acyl-alpha-hexosamines
- Alternative Parents
- Hexoses / Oxanes / Secondary alcohols / Hemiacetals / Propargyl-type 1,3-dipolar organic compounds / Polyols / Oxacyclic compounds / Carboximidic acids / Primary alcohols / Organopnictogen compounds show 2 more
- Substituents
- Alcohol / Aliphatic heteromonocyclic compound / Carboximidic acid / Carboximidic acid derivative / Hemiacetal / Hexose monosaccharide / Hydrocarbon derivative / Monosaccharide / N-acyl-alpha-hexosamine / Organic 1,3-dipolar compound show 10 more
- Molecular Framework
- Aliphatic heteromonocyclic compounds
- External Descriptors
- N-acetyl-D-galactosamine (CHEBI:40356)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 00C01APN10
- CAS number
- 14215-68-0
- InChI Key
- OVRNDRQMDRJTHS-CBQIKETKSA-N
- InChI
- InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8+/m1/s1
- IUPAC Name
- N-[(2S,3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- SMILES
- CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0000212
- PubChem Compound
- 84265
- PubChem Substance
- 46504848
- ChemSpider
- 76020
- ChEBI
- 40356
- ZINC
- ZINC000002562219
- PDBe Ligand
- A2G
- PDB Entries
- 1ax0 / 1bch / 1d0h / 1fnz / 1jlx / 1jot / 1kyj / 1llp / 1lti / 1lu1 … show 216 more
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 254.0 mg/mL ALOGPS logP -2.6 ALOGPS logP -3.2 Chemaxon logS 0.06 ALOGPS pKa (Strongest Acidic) 11.6 Chemaxon pKa (Strongest Basic) -1.6 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 5 Chemaxon Polar Surface Area 119.25 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 47.02 m3·mol-1 Chemaxon Polarizability 20.58 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.7474 Blood Brain Barrier - 0.8701 Caco-2 permeable - 0.8011 P-glycoprotein substrate Non-substrate 0.7455 P-glycoprotein inhibitor I Non-inhibitor 0.9078 P-glycoprotein inhibitor II Non-inhibitor 0.9643 Renal organic cation transporter Non-inhibitor 0.9538 CYP450 2C9 substrate Non-substrate 0.7133 CYP450 2D6 substrate Non-substrate 0.8366 CYP450 3A4 substrate Non-substrate 0.5839 CYP450 1A2 substrate Non-inhibitor 0.9657 CYP450 2C9 inhibitor Non-inhibitor 0.9516 CYP450 2D6 inhibitor Non-inhibitor 0.9655 CYP450 2C19 inhibitor Non-inhibitor 0.9403 CYP450 3A4 inhibitor Non-inhibitor 0.9856 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9634 Ames test Non AMES toxic 0.6765 Carcinogenicity Non-carcinogens 0.9735 Biodegradation Ready biodegradable 0.9156 Rat acute toxicity 1.5061 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9898 hERG inhibition (predictor II) Non-inhibitor 0.9666
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 149.5580534 predictedDarkChem Lite v0.1.0 [M-H]- 149.02118 predictedDeepCCS 1.0 (2019) [M+H]+ 149.0248534 predictedDarkChem Lite v0.1.0 [M+H]+ 151.41675 predictedDeepCCS 1.0 (2019) [M+Na]+ 148.5801534 predictedDarkChem Lite v0.1.0 [M+Na]+ 157.85878 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52